ampelopsin has been researched along with transforming growth factor beta in 2 studies
| Studies (ampelopsin) | Trials (ampelopsin) | Recent Studies (post-2010) (ampelopsin) | Studies (transforming growth factor beta) | Trials (transforming growth factor beta) | Recent Studies (post-2010) (transforming growth factor beta) |
|---|---|---|---|---|---|
| 377 | 2 | 343 | 49,119 | 560 | 17,610 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bao, S; Chen, N; Chen, X; Chen, Y; Li, M; Liu, B; Liu, J; Xu, F; Zhang, Q; Zhou, W; Zhu, R | 1 |
| Bao, S; Guan, X; Hao, S; Huang, X; Lian, T; Liu, B; Tan, X; Zhang, J; Zhu, R | 1 |
2 other study(ies) available for ampelopsin and transforming growth factor beta
| Article | Year |
|---|---|
Dihydromyricetin induces mouse hepatoma Hepal-6 cell apoptosis via the transforming growth factor-β pathway.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Proliferation; Flavonols; Liver Neoplasms; Mice; Models, Biological; NADPH Oxidase 4; NADPH Oxidases; Reactive Oxygen Species; Signal Transduction; Transforming Growth Factor beta | 2015 |
Dihydromyricetin Reduces TGF-β Via P53 Activation-dependent Mechanism in Hepatocellular Carcinoma HepG2 Cells.
Topics: Antineoplastic Agents; Apoptosis; Cell Proliferation; Flavonols; Hep G2 Cells; Humans; Transforming Growth Factor beta; Tumor Suppressor Protein p53 | 2017 |